Kymera Therapeutics, Inc.
NASDAQ:KYMR
48.63 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||||
| Current Assets: | |||||||||||||||||||
| Cash & Cash Equivalents
| 110.718 | 67.612 | 93.51 | 109.966 | 81.051 | 52.386 | 50.152 | 68.395 | 155.658 | 76.914 | 33.733 | 47.976 | 156.819 | 84.903 | 53.098 | 31.004 | 54.593 | 60.971 | 76.015 |
| Short Term Investments
| 439.252 | 442.341 | 427.034 | 264.915 | 276.774 | 315.188 | 346.725 | 338.771 | 326.25 | 315.395 | 387.079 | 394.442 | 379.567 | 274.204 | 280.439 | 265.198 | 239.248 | 94.994 | 15.942 |
| Cash and Short Term Investments
| 549.97 | 509.953 | 520.544 | 374.881 | 357.825 | 367.574 | 515.894 | 559.494 | 481.908 | 392.309 | 420.812 | 567.605 | 536.386 | 359.107 | 333.537 | 458.733 | 293.841 | 155.965 | 91.957 |
| Net Receivables
| 1.317 | 1.704 | 2.03 | 18.762 | 3.778 | 4.122 | 3.32 | 2.537 | 2.882 | 2.37 | 1.263 | 0.135 | 1.573 | 0.904 | 1.734 | 1.433 | 0.577 | 0 | 0 |
| Inventory
| -1.317 | 0 | 0 | 0 | 0 | 0 | -14.673 | -12.25 | 0 | 0 | 0 | -8.855 | 0 | 0 | 0 | -162.531 | 0 | 0 | 0 |
| Other Current Assets
| 18.745 | 13.75 | 14.679 | 11.674 | 14.091 | 13.706 | 11.353 | 9.713 | 18.464 | 16.182 | 9.307 | 17.44 | 11.544 | 4.795 | 5.52 | 9.408 | 2.946 | 2.336 | 0.888 |
| Total Current Assets
| 568.715 | 525.407 | 537.253 | 405.317 | 375.694 | 385.402 | 515.894 | 559.494 | 494.022 | 402.77 | 431.382 | 567.605 | 543.731 | 364.806 | 340.791 | 302.339 | 297.364 | 158.301 | 92.845 |
| Non-Current Assets: | |||||||||||||||||||
| Property, Plant & Equipment, Net
| 99.309 | 100.439 | 98.665 | 101.079 | 91.1 | 83.181 | 74.036 | 13.334 | 21.617 | 21.929 | 21.066 | 11.881 | 21.724 | 21.766 | 20.502 | 10.841 | 20.943 | 20.285 | 22.083 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 366.818 | 198.286 | 230.215 | 61.434 | 76.988 | 104.759 | 119.017 | 152.328 | 113.701 | 90.182 | 102.478 | 125.187 | 74.692 | 45.305 | 101.639 | 162.531 | 187.464 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 1.889 | 2.118 | 7.929 | 8.596 | 8.603 | -95.042 | -122.022 | 9.132 | 8.54 | 8.134 | -98.768 | 2.306 | 2.509 | 1.62 | 11.464 | 1.59 | 2.523 | 1.774 |
| Total Non-Current Assets
| 466.127 | 300.614 | 330.998 | 170.442 | 176.684 | 196.543 | 98.011 | 43.64 | 144.45 | 120.651 | 131.678 | 38.3 | 98.722 | 69.58 | 123.761 | 184.836 | 209.997 | 22.808 | 23.857 |
| Total Assets
| 1,034.842 | 826.021 | 868.251 | 575.759 | 552.378 | 581.945 | 613.905 | 603.134 | 638.472 | 523.421 | 563.06 | 605.905 | 642.453 | 434.386 | 464.552 | 487.175 | 507.361 | 181.109 | 116.702 |
| Liabilities & Equity: | |||||||||||||||||||
| Current Liabilities: | |||||||||||||||||||
| Account Payables
| 6.494 | 6.51 | 6.812 | 7.075 | 4.978 | 3.745 | 6.483 | 4.335 | 6.327 | 2.374 | 2.567 | 4.005 | 5.033 | 8.177 | 8.348 | 4.368 | 3.979 | 3.982 | 3.276 |
| Short Term Debt
| 3.321 | 24.832 | 9.89 | 12.69 | 7.19 | 7.594 | 3.893 | 3.943 | 7.238 | 7.312 | 7.134 | 3.599 | 7.264 | 6.926 | 6.096 | 3.261 | 2.733 | 3.705 | 3.377 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 20.024 | 19.259 | 22.613 | 37.883 | 27.352 | 24.302 | 57.114 | 63.26 | 55.776 | 59.46 | 60.852 | 101.034 | 66.234 | 82.263 | 87.912 | 170.39 | 92.011 | 27.289 | 23.349 |
| Other Current Liabilities
| 27.163 | 11.542 | 16.821 | 28.043 | 23.646 | 18.961 | 19.309 | 27.805 | 21.783 | 18.354 | 17.786 | 23.199 | 15.962 | 11.319 | 7.781 | 10.436 | 8.563 | 7.704 | 4.568 |
| Total Current Liabilities
| 66.532 | 62.143 | 56.136 | 85.691 | 63.166 | 54.602 | 123.543 | 63.26 | 91.124 | 87.5 | 88.339 | 101.034 | 94.493 | 108.685 | 110.137 | 110.617 | 107.286 | 42.68 | 34.57 |
| Non-Current Liabilities: | |||||||||||||||||||
| Long Term Debt
| 150.76 | 151.53 | 77.131 | 156.658 | 154.496 | 142.528 | 129.728 | 13.392 | 26.242 | 27.27 | 27.81 | 14.364 | 29.62 | 29.682 | 28.844 | 14.732 | 30.164 | 15.399 | 17.816 |
| Deferred Revenue Non-Current
| 0 | 3.189 | 23.781 | 16.768 | 16.421 | 20.421 | 24.866 | 28 | 21.086 | 24.071 | 31.823 | 39.295 | 49.939 | 52.672 | 64.654 | 77.838 | 90.308 | 18.987 | 29.642 |
| Deferred Tax Liabilities Non-Current
| 0 | -3.189 | -23.781 | -16.768 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -53.659 | 0 | 0 | 0 | 0 | -15.082 | 0 | -17.816 |
| Other Non-Current Liabilities
| -75.38 | -75.765 | 0 | -78.329 | -77.24 | -71.034 | -64.627 | 0.248 | -12.865 | -13.371 | -13.632 | 0.066 | -14.734 | -14.757 | -14.33 | 0.1 | -15.082 | 0 | 109.08 |
| Total Non-Current Liabilities
| 75.38 | 78.954 | 100.912 | 95.097 | 93.677 | 91.915 | 28.357 | 49.723 | 34.463 | 37.97 | 46.001 | 45.233 | 64.825 | 67.597 | 79.168 | 92.67 | 105.39 | 34.386 | 156.538 |
| Total Liabilities
| 141.912 | 141.097 | 157.048 | 180.788 | 156.843 | 146.517 | 151.9 | 112.983 | 125.587 | 125.47 | 134.34 | 146.267 | 159.318 | 176.282 | 189.305 | 203.287 | 212.676 | 77.066 | 191.108 |
| Equity: | |||||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 507.361 | 0 | 0 |
| Common Stock
| 0.007 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.004 | 0.004 | 0.004 | 0.003 | 0 |
| Retained Earnings
| -683.858 | -621.371 | -579.309 | -530.752 | -516.384 | -463.517 | -424.718 | -383.79 | -348.925 | -305.923 | -265.666 | -228.982 | -195.082 | -166.5 | -141.84 | -128.765 | -116.08 | -108.094 | -76.456 |
| Accumulated Other Comprehensive Income/Loss
| 1.931 | -2.099 | -1.777 | -0.552 | -2.45 | -3.635 | -3.038 | -4.949 | -5.913 | -3.983 | -3.216 | -0.66 | -0.146 | 0 | -0.013 | -0.128 | -0.164 | 0.031 | 0.006 |
| Other Total Stockholders Equity
| 1,574.85 | 1,308.388 | 1,292.283 | 926.269 | 914.363 | 902.574 | 889.755 | 878.884 | 867.717 | 707.852 | 697.597 | 689.275 | 678.358 | 424.599 | 417.096 | 412.777 | 410.925 | 212.106 | 2.044 |
| Total Shareholders Equity
| 892.93 | 684.924 | 711.203 | 394.971 | 395.535 | 435.428 | 462.005 | 490.151 | 512.885 | 397.951 | 428.72 | 459.638 | 483.135 | 258.104 | 275.247 | 283.888 | 294.685 | 104.043 | -74.406 |
| Total Equity
| 892.93 | 684.924 | 711.203 | 394.971 | 395.535 | 435.428 | 462.005 | 490.151 | 512.885 | 397.951 | 428.72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities & Shareholders Equity
| 1,034.842 | 826.021 | 868.251 | 575.759 | 552.378 | 581.945 | 613.905 | 603.134 | 638.472 | 523.421 | 563.06 | 605.905 | 642.453 | 434.386 | 464.552 | 487.175 | 507.361 | 181.109 | 116.702 |